Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T Penson

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
The Oncologist|June 26, 2001
Losing GodR T Penson, R Z Yusuf, B A Chabner, et al.
The British Journal of Surgery|December 1, 1994
Combination chemotherapy with epirubicin, cisplatin and 5-fluorouracil for the palliation of advanced gastric and oesophageal adenocarcinomaM S Highley, F X Parnis, G A Trotter, et al.
Gynecologic Oncology|August 7, 2004
Attitudes to chemotherapy in patients with ovarian cancerR T Penson, F Dignan, M V Seiden, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 14, 2005
A phase II study of fixed dose rate gemcitabine in patients with relapsed müllerian tumorsR T Penson, S M Campos, M V Seiden, et al.
Gynecologic Oncology|March 29, 2006
Phase I/II dose finding study of combination cisplatin and gemcitabine in patients with recurrent cervix cancerU A Matulonis, S Campos, L Duska, et al.
Gynecologic Oncology|May 2, 2001
The clinical utility of liposomal doxorubicin in recurrent ovarian cancerS M Campos, R T Penson, A R Mays, et al.
Gynecologic Oncology|June 30, 2006
Three sequential chemotherapy doublets for the treatment of newly diagnosed advanced müllerian malignancies: the modified triple doublet regimenU A Matulonis, S Campos, C N Krasner, et al.
Cancer|September 26, 2001
A Phase I-II study of 96-hour infusional topotecan and paclitaxel for patients with recurrent Müllerian tumorsR T Penson, J G Supko, M V Seiden, et al.
British Journal of Cancer|June 30, 2005
A phase I clinical trial of continual alternating etoposide and topotecan in refractory solid tumoursR T Penson, M V Seiden, U A Matulonis, et al.
British Journal of Cancer|July 1, 2010
A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumoursU Lassen, L R Molife, M Sorensen, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
The Oncologist|June 26, 2001
Losing GodR T Penson, R Z Yusuf, B A Chabner, et al.
The British Journal of Surgery|December 1, 1994
Combination chemotherapy with epirubicin, cisplatin and 5-fluorouracil for the palliation of advanced gastric and oesophageal adenocarcinomaM S Highley, F X Parnis, G A Trotter, et al.
Gynecologic Oncology|August 7, 2004
Attitudes to chemotherapy in patients with ovarian cancerR T Penson, F Dignan, M V Seiden, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 14, 2005
A phase II study of fixed dose rate gemcitabine in patients with relapsed müllerian tumorsR T Penson, S M Campos, M V Seiden, et al.
Gynecologic Oncology|March 29, 2006
Phase I/II dose finding study of combination cisplatin and gemcitabine in patients with recurrent cervix cancerU A Matulonis, S Campos, L Duska, et al.
Gynecologic Oncology|May 2, 2001
The clinical utility of liposomal doxorubicin in recurrent ovarian cancerS M Campos, R T Penson, A R Mays, et al.
Gynecologic Oncology|June 30, 2006
Three sequential chemotherapy doublets for the treatment of newly diagnosed advanced müllerian malignancies: the modified triple doublet regimenU A Matulonis, S Campos, C N Krasner, et al.
Cancer|September 26, 2001
A Phase I-II study of 96-hour infusional topotecan and paclitaxel for patients with recurrent Müllerian tumorsR T Penson, J G Supko, M V Seiden, et al.
British Journal of Cancer|June 30, 2005
A phase I clinical trial of continual alternating etoposide and topotecan in refractory solid tumoursR T Penson, M V Seiden, U A Matulonis, et al.
British Journal of Cancer|July 1, 2010
A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumoursU Lassen, L R Molife, M Sorensen, et al.
Pageof 5